Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Catherine Chanfreau-Coffinier"'
Autor:
Alexandra L. Clark, Makenna B. McGill, Erin D. Ozturk, David M. Schnyer, Catherine Chanfreau-Coffinier, Victoria C. Merritt, the VA Million Veteran Program
Publikováno v:
Military Medical Research, Vol 10, Iss 1, Pp 1-12 (2023)
Abstract Background Examining the health outcomes of veterans who have completed the United States Veterans Health Administration’s (VHA’s) Traumatic Brain Injury (TBI) Screening and Evaluation Program may aid in the refinement and improvement of
Externí odkaz:
https://doaj.org/article/ba1905942ed04a4abfb628205f0a0ed2
Autor:
Victoria C. Merritt, Catherine Chanfreau-Coffinier, McKenna S. Sakamoto, Amy J. Jak, Lisa Delano-Wood
Publikováno v:
Clin Psychol Sci
Clinical psychological science : a journal of the Association for Psychological Science, vol 2022, iss 2
Clinical psychological science : a journal of the Association for Psychological Science, vol 2022, iss 2
Using a diverse sample of military veterans enrolled in the Veteran Affairs (VA) Million Veteran Program ( N = 14,378; n = 1,361 females [9.5%]; all previously deployed), we examined sex differences on the Comprehensive Traumatic Brain Injury Evaluat
Autor:
Victoria C. Merritt, Adam X. Maihofer, Marianna Gasperi, Elizabeth Ketema, Catherine Chanfreau-Coffinier, Murray B. Stein, Matthew S. Panizzon, Richard L. Hauger, Mark W. Logue, Lisa Delano-Wood, Caroline M. Nievergelt
Large-scale genetic studies of traumatic brain injury (TBI) are lacking; thus, our understanding of the influence of genetic factors on TBI risk and recovery is incomplete. This study aimed to conduct a genome-wide association study (GWAS) of TBI in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02423d83f0025ccc50092a01abe6f2f2
https://doi.org/10.1101/2023.02.16.23286045
https://doi.org/10.1101/2023.02.16.23286045
Autor:
Erin D. Ozturk, Catherine Chanfreau-Coffinier, McKenna S. Sakamoto, Lisa Delano-Wood, Victoria C. Merritt
Publikováno v:
J Psychiatr Res
The purpose of this study was to examine neurobehavioral symptom reporting in a large sample of military veterans (N = 12,144) who completed the Comprehensive Traumatic Brain Injury Evaluation (CTBIE) and enrolled in the VA's Million Veteran Program
Autor:
Olivia M. Dong, Salvador Rivas, Michael Naglich, Nina R. Sperber, Catherine Chanfreau-Coffinier, Kara L. Gavin, Megan C. Roberts, Jill S Bates, Jason L. Vassy, R. Ryanne Wu, Deepak Voora, Maria Ribeiro, Michael J. Kelley, Peruvemba Sriram, Corrine I. Voils, C. William Heise, Jennifer G Chapman
Publikováno v:
Pharmacogenomics
Aim: The first Plan-Do-Study-Act cycle for the Veterans Affairs Pharmacogenomic Testing for Veterans pharmacogenomic clinical testing program is described. Materials & methods: Surveys evaluating implementation resources and processes were distribute
Autor:
Julian Brunner, Melissa M. Farmer, Bevanne Bean-Mayberry, Catherine Chanfreau-Coffinier, Claire T. Than, Alison B. Hamilton, Erin P. Finley
Publikováno v:
Frontiers in Health Services. 2
Evaluations of clinical decision support (CDS) implementation often struggle to measure and explain heterogeneity in uptake over time and across settings, and to account for the impact of context and adaptation on implementation success. In 2017–20
Publikováno v:
Eur Heart J Qual Care Clin Outcomes
Aims CYP2C19-guided P2Y12 inhibitor selection can reduce cardiovascular (CV) events and bleeding in patients with acute coronary syndromes (ACSs) post-percutaneous coronary intervention (PCI). The 12-month cost-effectiveness of CYP2C19-guided P2Y12 i
Autor:
Michael J. Kelley, Russell Jacobitz, Craig William Heise, Susan Rozelle, Salvador Rivas, Michael Icardi, Olivia M. Dong, Jason L. Vassy, Deepak Voora, Peruvemba Sriram, Laurence Meyer, Michael Naglich, Catherine Chanfreau-Coffinier, Jennifer G Chapman, Jill S Bates, Maria Ribeiro
Publikováno v:
Pharmacogenomics. 22:137-144
In 2019, the Veterans Affairs (VA), the largest integrated US healthcare system, started the Pharmacogenomic Testing for Veterans (PHASER) clinical program that provides multi-gene pharmacogenomic (PGx) testing for up to 250,000 veterans at approxima
Autor:
Alexandra L, Clark, Makenna B, McGill, Erin D, Ozturk, David M, Schnyer, Catherine, Chanfreau-Coffinier, Victoria C, Merritt
Publikováno v:
Military Medical Research. 10(1)
Examining the health outcomes of veterans who have completed the United States Veterans Health Administration's (VHA's) Traumatic Brain Injury (TBI) Screening and Evaluation Program may aid in the refinement and improvement of clinical care initiativ
Autor:
Craig William Heise, Jason L. Vassy, Ronald M. Przygodzki, Annjanette Stone, Victoria M. Pratt, Deepak Voora, Maren T. Scheuner, Leland E. Hull, Jessica Wang-Rodriguez, Corrine I. Voils, Catherine Chanfreau-Coffinier, Steven A. Schichman
Publikováno v:
J Mol Diagn
Pharmacogenetics (PGx) testing can be used for detecting genetic variations that may affect an individual's anticipated metabolism of, or response to, medications. Although several studies have focused on developing tools for delivering results from